Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-14-Speech-1-202-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Cord blood stem cells (debate)2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20110214.18.1-202-000"2
lpv:hasSubsequent	lp_eu:2011-02-14-Speech-1-202-5002
lpv:speaker	lp:Elena Oana Antonescu2
lpv:spokenAs	substitute; LIBE (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the Mashreq countries (2009-09-16--2014-06-30)3 unknown; Partidul Democrat-Liberal (2009-07-14--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2012-10-21)3
lpv:translated text	"The value of the global market for cord blood stem cells was approximately EUR 3.34 billion in 2010. Future projections, based on an annual growth rate of roughly 27% in the coming years, indicate that this figure will reach EUR 11 billion by 2015. At a time when stem cells seem to be the new ‘El Dorado’ in medical research, many researchers are in a hurry to move into this niche area without ensuring that they achieve all the quality and safety standards required for these procedures. I think that the Commission must step up its efforts in terms of informing patients and medical staff about the benefits of extracting cord blood stem cells. However, it must also make a special effort to ensure that the minimum quality and safety standards for donating, acquiring, testing, processing, keeping, storing and distributing human cells and tissue are, and will be, complied with in all Member States."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph